FDA review of published and unpublished literature estimates that the “prevalence of unsuspected uterine leiomysosarcoma is 1 in 352.” The FDA go on to write that this number was higher than previously understandable.
An FDA review of published and unpublished literature estimates that the “prevalence of unsuspected uterine leiomysosarcoma is 1 in 352.” The FDA went on to write that this number was higher than previously understood.